{"id":"https://openalex.org/W2961844706","doi":null,"title":"COST EFFECTIVENESS ANALYSIS OF ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) AFTER DOCETAXEL THERAPY","display_name":"COST EFFECTIVENESS ANALYSIS OF ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) AFTER DOCETAXEL THERAPY","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2961844706","mag":"2961844706"},"language":"en","primary_location":{"id":"pmh:oai:digitalrepository.unm.edu:phrm_etds-1019","doi":null,"is_oa":false,"landing_page_url":"https://digitalrepository.unm.edu/phrm_etds/21","pdf_url":null,"source":{"id":"https://openalex.org/S4377196368","display_name":"UNM\u2019s Digital Repository (University of New Mexico)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169521973","host_organization_name":"University of New Mexico","host_organization_lineage":["https://openalex.org/I169521973"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Sciences ETDs","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065537882","display_name":"Yazan K. Barqawi","orcid":"https://orcid.org/0000-0002-3045-6813","observed_orcids":["https://orcid.org/0000-0002-3045-6813"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yazan K. Barqawi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5065537882"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7070000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7070000171661377,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.2468000054359436,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.7889999747276306},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/visceral-metastasis","display_name":"visceral metastases","score":0.8920000195503235},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.7730000019073486},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.8119999766349792},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8610000014305115},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6690000295639038},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4650000035762787},{"id":"https://openalex.org/keywords/healthcare-payer-perspective","display_name":"healthcare payer perspective","score":0.6309999823570251},{"id":"https://openalex.org/keywords/nccn-guidelines","display_name":"NCCN guidelines","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.9691759943962097},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.9599403142929077},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8983373641967773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8460960984230042},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8224105834960938},{"id":"https://openalex.org/C2776421732","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone","level":5,"score":0.8001152276992798},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.7225354313850403},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6116989254951477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4336223900318146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.375882089138031},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3402608036994934},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.33994704484939575},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.08852756023406982}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digitalrepository.unm.edu:phrm_etds-1019","doi":null,"is_oa":false,"landing_page_url":"https://digitalrepository.unm.edu/phrm_etds/21","pdf_url":null,"source":{"id":"https://openalex.org/S4377196368","display_name":"UNM\u2019s Digital Repository (University of New Mexico)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169521973","host_organization_name":"University of New Mexico","host_organization_lineage":["https://openalex.org/I169521973"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Sciences ETDs","raw_type":"text"},{"id":"mag:2961844706","doi":null,"is_oa":false,"landing_page_url":"https://digitalrepository.unm.edu/cgi/viewcontent.cgi?article=1019&context=phrm_etds","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":96,"referenced_works":["https://openalex.org/W82517701","https://openalex.org/W85469694","https://openalex.org/W92438785","https://openalex.org/W107470920","https://openalex.org/W1480366037","https://openalex.org/W1493990568","https://openalex.org/W1517224081","https://openalex.org/W1904433804","https://openalex.org/W1972388955","https://openalex.org/W1975366467","https://openalex.org/W1978663841","https://openalex.org/W1982886256","https://openalex.org/W1993795505","https://openalex.org/W1996389184","https://openalex.org/W2002395040","https://openalex.org/W2021775688","https://openalex.org/W2027590825","https://openalex.org/W2037204324","https://openalex.org/W2038397362","https://openalex.org/W2041532444","https://openalex.org/W2045961918","https://openalex.org/W2050056063","https://openalex.org/W2054917262","https://openalex.org/W2055346449","https://openalex.org/W2060717021","https://openalex.org/W2061172256","https://openalex.org/W2064950402","https://openalex.org/W2069995517","https://openalex.org/W2071806619","https://openalex.org/W2077521143","https://openalex.org/W2078354362","https://openalex.org/W2081084828","https://openalex.org/W2093941725","https://openalex.org/W2095095509","https://openalex.org/W2102917900","https://openalex.org/W2103633761","https://openalex.org/W2103793201","https://openalex.org/W2103959341","https://openalex.org/W2107270081","https://openalex.org/W2109621894","https://openalex.org/W2110534364","https://openalex.org/W2118498521","https://openalex.org/W2118564089","https://openalex.org/W2119391023","https://openalex.org/W2120292596","https://openalex.org/W2121023961","https://openalex.org/W2122376802","https://openalex.org/W2123526148","https://openalex.org/W2125837480","https://openalex.org/W2129128353","https://openalex.org/W2131723590","https://openalex.org/W2132315278","https://openalex.org/W2135078918","https://openalex.org/W2136919572","https://openalex.org/W2137467802","https://openalex.org/W2137926053","https://openalex.org/W2138029397","https://openalex.org/W2140665438","https://openalex.org/W2141454098","https://openalex.org/W2142391938","https://openalex.org/W2143025931","https://openalex.org/W2143532751","https://openalex.org/W2148643283","https://openalex.org/W2150712216","https://openalex.org/W2153709799","https://openalex.org/W2157117527","https://openalex.org/W2159771669","https://openalex.org/W2165542862","https://openalex.org/W2166775256","https://openalex.org/W2166918329","https://openalex.org/W2168108459","https://openalex.org/W2170731023","https://openalex.org/W2179708332","https://openalex.org/W2187751749","https://openalex.org/W2277217315","https://openalex.org/W2278566359","https://openalex.org/W2292137525","https://openalex.org/W2296253991","https://openalex.org/W2312988633","https://openalex.org/W2340422569","https://openalex.org/W2341295406","https://openalex.org/W2483834070","https://openalex.org/W2512576260","https://openalex.org/W2514356379","https://openalex.org/W2516969383","https://openalex.org/W2537819449","https://openalex.org/W2559912395","https://openalex.org/W2562690956","https://openalex.org/W2566433825","https://openalex.org/W2568045406","https://openalex.org/W2603911915","https://openalex.org/W2735211627","https://openalex.org/W2772562756","https://openalex.org/W2792086148","https://openalex.org/W2991248234","https://openalex.org/W4301042653"],"related_works":["https://openalex.org/W2931451269","https://openalex.org/W2953452094","https://openalex.org/W2970590492","https://openalex.org/W2024758584","https://openalex.org/W2408491936","https://openalex.org/W2762424895","https://openalex.org/W2079874793","https://openalex.org/W7099007965","https://openalex.org/W2246090340","https://openalex.org/W2267983202"],"abstract_inverted_index":{"Background:":[0],"Prostate":[1],"cancer":[2,12,29,46,73,88],"is":[3,488,509],"the":[4,16,75,89,110,164,197,212,220,275,286,330,478],"second":[5],"leading":[6],"cause":[7],"of":[8,51,56,100,112,182,223,247,252,274,290,332,350,393,468],"death":[9],"after":[10],"lung":[11],"among":[13],"men":[14],"in":[15,31,74,196,200,244,375],"US.":[17],"The":[18],"America":[19],"Cancer":[20,134],"Society":[21],"predicts":[22],"164,690":[23],"new":[24],"cases":[25,58],"and":[26,53,77,105,159,172,225,258,266,281,309,335,365,401,417,427,430,436,455,470,496,512],"29,430":[27],"prostate":[28,37,45,72,87],"deaths":[30],"2018.":[32],"Of":[33],"those":[34,57],"diagnosed":[35],"with":[36,443],"cancer,":[38],"about":[39],"10-20":[40],"%":[41,55,246],"will":[42,59,386],"develop":[43],"castration-resistant":[44],"(CRPC)":[47],"within":[48],"5":[49,245],"years":[50],"diagnosis":[52],"70":[54],"metastasize":[60],"to":[61,79,139,162,328,373,411,421,449,477,491,516],"mCRPC.":[62],"In":[63,378],"2014,":[64],"nearly":[65],"US":[66,76,81,119,188,202,502],"$13.4":[67],"billion":[68,83],"was":[69,149,326,409,440],"spent":[70],"on":[71],"expected":[78,372],"reach":[80],"$15.4":[82],"by":[84,155],"2020;":[85],"making":[86],"fifth":[90],"most":[91],"costly":[92,514],"cancer.":[93],"Objective:":[94],"To":[95],"conduct":[96],"a":[97,118,187,295,501],"cost-effective":[98,489],"analysis":[99,325,334],"enzalutamide,":[101],"abiraterone":[102,354,402,422,450,482,492],"plus":[103,107,278,283,356,363,397,404,423,432,452,457,461,484,494,498,507,518],"prednisone":[104,108,364,398,405,424,433,453,458,462,495,499,508],"cabazitaxel":[106,282,362,396,431,456,497,517],"for":[109,209,272],"treatment":[111],"visceral":[113,141,183,248],"mCRPC":[114,142,184,249],"post-docetaxel":[115,143],"failure":[116],"from":[117,186,285,500],"healthcare":[120,189,503],"payer":[121],"perspective":[122],"utilizing":[123],"life-time":[124],"horizon":[125],"Markov":[126],"model.":[127],"These":[128],"medications":[129],"received":[130],"highest":[131],"National":[132],"Comprehensive":[133],"Network":[135],"(NCCN)":[136],"guideline":[137],"recommendation":[138],"treat":[140],"failure.":[144],"Methods:":[145],"A":[146],"pharmacoeconomic":[147],"model":[148,198,205],"constructed":[150],"using":[151,294],"Microsoft":[152],"Excel\u00ae":[153],"supported":[154],"visual":[156],"basic":[157],"codes":[158],"macros":[160],"functions":[161],"estimate":[163],"cost-effectiveness":[165,300,337],"[cost":[166,175,303,314],"per":[167,176,219,304,315],"life":[168,179,305,318],"year":[169,180,306,319],"gained":[170,307],"(LYG)]":[171,308],"cost-utility":[173,311],"analyses":[174],"quality":[177,316],"adjusted":[178,208,317],"(QALY)]":[181,320],"therapies":[185],"perspective.":[190,504],"We":[191,261],"included":[192],"direct":[193],"medical":[194,213],"costs":[195,206,227,251,446],"expressed":[199],"2018":[201,224],"dollars.":[203],"All":[204],"were":[207,228,321],"inflation":[210],"through":[211],"consumer":[214],"price":[215],"index":[216],"(MCPI)":[217],"as":[218],"1st":[221],"quarter":[222],"future":[226],"discounted":[229],"at":[230,242,340],"3":[231,376],"%,":[232],"(i.e.":[233],"drug":[234],"costs,":[235],"grade":[236],"(\u22653)":[237],"adverse":[238],"events":[239],"that":[240],"occurred":[241],"least":[243],"patients,":[250],"physician":[253],"follow":[254],"up,":[255],"needed":[256],"blood":[257],"imaging":[259],"investigations).":[260],"calculated":[262],"overall":[263],"survival":[264,268,288],"(OS)":[265],"progression-free":[267],"(PFS)":[269],"transition":[270],"probabilities":[271],"each":[273],"alternatives":[276],"(abiraterone":[277],"prednisone,":[279,357],"enzalutamide":[280,370,385],"prednisone)":[284],"Kaplan-Meier":[287],"curves":[289],"phase":[291],"III":[292],"trials":[293],"digitizing":[296],"program":[297],"(Webplotdigitizer).":[298],"Incremental":[299],"ratios":[301,312],"(ICERs)":[302],"incremental":[310],"(ICURs)":[313],"calculated.":[322],"Probabilistic":[323],"sensitivity":[324],"conducted":[327],"assess":[329],"robustness":[331],"base-case":[333],"provide":[336],"acceptability":[338],"curve":[339],"various":[341],"willingness-to-pay":[342],"thresholds.":[343],"Results:":[344],"Model":[345],"results":[346],"indicate":[347],"(98.7":[348],"%)":[349,359,367,392,400],"patients":[351,382],"who":[352,360,368,383],"receive":[353,361,369,384],"acetate":[355,403,451,483,493,506],"(83.8":[358],"(86.8":[366],"are":[371],"die":[374],"years.":[377],"1.5":[379],"years\u2019":[380],"time,":[381],"have":[387],"significantly":[388],"higher":[389],"rates":[390],"(14.47":[391],"PFS":[394],"than":[395],"(0.27":[399],"(0.51":[406],"%).":[407],"Enzalutamide":[408,439,487],"found":[410],"be":[412],"more":[413],"effective":[414,511],"(1.58":[415],"LYG":[416,426,435],"0.79":[418],"QALY)":[419,429],"compared":[420,448,476,490,515],"(1.20":[425],"0.58":[428],"(1.48":[434],"0.56":[437],"QALY).":[438],"also":[441],"associated":[442],"lower":[444],"total":[445],"($157,830)":[447],"($235,853)":[454],"($496,756).":[459],"Cabazitaxel":[460],"had":[463],"an":[464],"ICER":[465],"&":[466],"ICUR":[467],"$931.7K/LYG":[469],"almost":[471],"13":[472],"million/QALY":[473],"respectively":[474],"when":[475],"next":[479],"lowest":[480],"treatment,":[481],"prednisone.":[485,519],"Conclusion:":[486],"Abiraterone":[505],"less":[510,513]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-23T00:00:00"}